SCHEMBL5806526

SCHEMBL5806526

Cc1nc(-c2ccc(OC(F)(F)F)cc2)nc2sc(OC(N)=O)c(N)c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.43
▸ SCN9A Q15858 3/20 0.39
▸ FPR2 P25090 2/20 0.39
▸ PPARD Q03181 2/20 0.38
▸ PPARA Q07869 1/20 0.38
▸ ABCG2 Q9UNQ0 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ CHRNA7 P36544 3/20 0.37
▸ ABL1 P00519 1/20 0.37
▸ BCR P11274 1/20 0.37
▸ JAK2 O60674 1/20 0.37
▸ JAK1 P23458 1/20 0.37
▸ TYK2 P29597 1/20 0.37
▸ JAK3 P52333 1/20 0.37
▸ SCN10A Q9Y5Y9 1/20 0.36
▸ BCHE P06276 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2856060 0.84 MAPT (0.42) MAPTMEN1KMT2AABCG2TP53
SCHEMBL5816926 0.84 MAPT (0.43) MAPTMEN1KMT2APPARDPPARA
SCHEMBL5808457 0.84 MAPT (0.43) MAPTMEN1KMT2AABCG2TP53
SCHEMBL5806520 0.84 MAPT (0.45) MAPTMEN1KMT2AABCG2TP53
SCHEMBL5808461 0.83 MAPT (0.57) MAPTMEN1KMT2ATP53SMN1; SMN2
SCHEMBL5808459 0.82 MEN1 (0.46) MAPTMEN1KMT2ATP53
SCHEMBL5820468 0.81 MAPT (0.45) MAPTMEN1KMT2AABCG2TP53
SCHEMBL5809433 0.81 MEN1 (0.43) MAPTMEN1KMT2ASCN9AFPR2
SCHEMBL5809220 0.76 KMT2A (0.44) MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL5805681 0.75 MAPT (0.46) MAPTMEN1KMT2AADORA3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006100095-A1 SUBSTITUTED CARBOXAMIDES METHOD FOR PRODUCTION AND USE THEREOF AS TNF-ALPHA RELEASE INHIBITORS CURACYTE DISCOVERY GMBH (DE) 2006-09-28 — — WO disclosed
Send feedback